MedPath

Gastric fundic gland polyps in patients undergoing routine upper gastrointestinal endoscopy

Recruiting
Conditions
gastric fundic gland polyps
10017934
Registration Number
NL-OMON30802
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
900
Inclusion Criteria

age > or = 18 years
signed informed consent
cases: endoscopical presence of gastric fundic gland polyps
controls: no endoscopical presence of gastric fundic gland polyps

Exclusion Criteria

coagulation disorder
use of warfarin or other anti-coagulant medication if uncorrected at the time of endoscopy
liver cirrhosis

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Description of<br /><br>- the prevalence of gastric fundic gland polyps in this population<br /><br>- the prevalence of dysplasia in these gastric fundic gland polyps<br /><br>- the prevalence of gastritis, atrophy, intestinal metaplasia, dysplasia and<br /><br>Helicobacter pylori<br /><br>- the serum levels of gastrin, pepsinogen I and II, and anti-Helicobacter<br /><br>pylori antibodies.<br /><br>- the results of the questionnaire assessment</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath